27 May 2024 : Clinical Research
Percutaneous Coronary Intervention as a Non-Surgical Treatment for Ischemic Mitral Regurgitation in Patients with Multi-Vessel Coronary Artery Disease
Xiaoyan Wang
1ABCE*, Zhihong Liu 1ABCDE, Aoyun Rong 1ABDE, Bofei Ma 1BCDE, Ruixing Mo 1BCEG
DOI: 10.12659/MSM.943122
Med Sci Monit 2024; 30:e943122
Table 1 Baseline data of the 15 enrolled patients.
| Baseline data | Value (n, %) |
|---|---|
| CAD type | |
| Unstable angina | 6 (40) |
| Acute myocardial infarction | 9 (60) |
| Age (years), mean (range) | 77.27 (61–92) |
| Sex | |
| Male | 12 (80) |
| Female | 3 (20) |
| Body mass index (kg/m) | 21.09±2.14 |
| MVD | |
| Two-vessel | 2 (13.33) |
| Three-vessel | 13 (86.67) |
| MR severity | |
| Mild | 0 |
| Moderate | 11 |
| Severe | 4 |
| Risk factors | |
| Smoking | 7 (46.67) |
| Hypertension | 11 (73.33) |
| Diabetes mellitus | 4 (26.67) |
| Cerebral infarction | 1 (6.67) |
| Heart rate (beats/min) | 67.73±11.04 |
| Grade II–IV/VI systolic murmur at the apex | 12 (80) |
| ECG findings | |
| Normal | 4 (26.67) |
| Atrioventricular block | 1 (6.67) |
| ST-segment elevation or ST depression | 10 (66.67) |
| SBP (mmHg) | 125.20±16.68 |
| DBP (mmHg) | 74.80±7.40 |
| Total cholesterol (mmol/L) | 4.93±1.44 |
| Triglyceride (mmol/L) | 1.98±2.17 |
| HDL-C (mmol/L) | 1.24±0.42 |
| LDL-C (mmol/L) | 3.17±0.72 |
| Creatinine (μmol/L) | 87.85±11.67 |
| Glomerular filtration rate (mL/min/1.73 m) | 72.39±13.40 |
| NT-proBNP (pg/mL) | 1584±1127.95 |
| Coronary artery dominance | |
| Right-dominant | 11 (73.33) |
| Left-dominant | 2 (13.33) |
| Co-dominance | 2 (13.33) |
| Number of stents implanted in PCI | 4.60±1.08 |
| SBP – systolic blood pressure; DBP – diastolic blood pressure; HDL-C – high-density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol; NT-proBNP – N-terminal Pro-B-type natriuretic peptide; MVD – multi-vessel coronary artery disease; MR – mitral regurgitation; ECG – electrocardiogram. | |